渝三峡A：出售北陆药业300万股股票，预计增加净利润约1855万元

Core Viewpoint - The company, Yuzhong Sanxia A, announced the sale of 3 million shares of Beilu Pharmaceutical, which is expected to increase net profit by approximately 18.55 million yuan after deducting costs and related transaction taxes [1] Financial Impact - The estimated increase in net profit from the sale of shares is about 18.55 million yuan, subject to final audit by the accounting firm for the impact on the company's net profit in 2026 [1]